C-Reactive Protein (CRP)
C-reactive protein represents the most commonly measured inflammatory marker. Elevated CRP (>3 mg/L) correlates with increased cardiovascular disease, metabolic disease, and cancer risk. CRP testing provides accessible inflammation assessment.
Cytokine Markers
Interleukins (IL-6, IL-10) and tumor necrosis factor (TNF-alpha) represent inflammatory cytokines. While powerful indicators, these markers require specialized testing unavailable in standard medical practice.
Lipoprotein-Associated Phospholipase A2 (Lp-PLA2)
This inflammatory marker specifically associated with arterial inflammation predicts cardiovascular events. Some labs offer testing, providing more specific assessment than CRP alone.
Homocysteine
Elevated homocysteine (>10 umol/L) associates with cardiovascular disease, cognitive decline, and inflammatory bone metabolism. B-vitamin supplementation (B6, B12, folate) reduces homocysteine effectively.
Fibrinogen
Elevated fibrinogen increases clotting risk and inflammatory burden. This marker correlates with cardiovascular events and shows responsiveness to lifestyle changes.
Fasting Glucose and Insulin
These markers indicate metabolic dysfunction and insulin resistance—driving inflammation. Fasting glucose >100 mg/dL or fasting insulin >12 mIU/L indicate metabolic concern warranting intervention.
Advanced Lipid Panel
Standard cholesterol panels miss important risk factors. Advanced lipid testing measures particle size and LDL particle number, providing superior cardiovascular risk assessment than total cholesterol alone.
Practical Testing Strategy
Standard testing—CRP, glucose, insulin, lipid panel—provides reasonable inflammation and metabolic assessment. More specialized testing requires specific clinical context. Trending biomarkers over time with lifestyle changes demonstrates intervention effectiveness.
Intervention Response
Lifestyle modifications showing fastest inflammation reduction: weight loss, exercise, Mediterranean diet, stress reduction, and sleep optimization. Most people see meaningful biomarker improvements within 6-8 weeks consistent practice.
Prevention Strategy
Use biomarker testing to identify risk early, motivating preventive intervention before disease development. Track trending to confirm intervention effectiveness and maintain adherence.
← Back to Home